Quality of Life in Patients with Fibromyalgia
DOI:
https://doi.org/10.12970/2310-8231.2013.01.01.1Keywords:
Fibromyalgia, quality of life, pain, pain management, multidisciplinary approach.Abstract
Objectives: The aim of this review is to provide practicing clinicians with detailed information on the quality of life (QoL) of patients with fibromyalgia, and the medical and non-medical management effects on quality of life in fibromyalgia.
Methods: A systematic English language search of the medical literature from January 1980 to January 2013 using PubMed was conducted using the search terms “fibromyalgia” AND “quality of life.” The literature search revealed 1,086 publications; 259 were clinical trials on human patients, 230 were reviews and 20 were case reports. Three authors reached a consensus on selecting the studies based on specific inclusion and exclusion criteria. A total of 95 research studies were included in this review.
Results: Overall quality of life is severely impaired in patients with fibromyalgia. Comorbidities have a further negative impact on QoL. Substantial pain reductions resulting in improvement of QoL were observed with medications and non-medication interventions such as exercise, acupuncture, cognitive behavioral therapy, neurofeedback and multidisciplinary approach.
Conclusion: Fibromyalgia and its comorbidities including pain have a considerable negative impact on the quality of life of fibromyalgia patients. Substantial or moderate pain reduction seems to improve quality of life. A multidisciplinary approach appears to be most beneficial in management of this multifaceted illness, but more studies are needed to develop specific interventions necessary to alleviate pain and sufferings in these patients.
References
Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 2010; 62: 600-10. http://dx.doi.org/10.1002/acr.20140
Mease PJ, Arnold LM, Crofford LJ, et al. Identifying the clinical domains of fibromyalgia: contributions from clinician and patient delphi exercises. Arthritis Rheum 2008; 59: 952-60. http://dx.doi.org/10.1002/art.23826
Goldenberg DL. Pain/Depression Dyad: A Key to a Better Understanding and Treatment of Functional Somatic Syndromes. The Am J Med 2010; 123: 675-82. http://dx.doi.org/10.1016/j.amjmed.2010.01.014
Busch AJ, Webber SC, Brachaniec M, et al. Exercise Therapy for Fibromyalgia. Curr Pain Headache Rep 2011; 15: 358-67. http://dx.doi.org/10.1007/s11916-011-0214-2
Lawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008; 58: 26-35. http://dx.doi.org/10.1002/art.23176
Ovayolu N, Ovayolu O, Karadag G. Health-related quality of life in ankylosing spondylitis, fibromyalgia syndrome, and rheumatoid arthritis: a comparison with a selected sample of healthy individuals. Clin Rheumatol 2011; 30: 655-64. http://dx.doi.org/10.1007/s10067-010-1604-2
Salaffi F, Sarzi-Puttini P, Girolimetti R, Atzeni F, Gasparini S, Grassi W. Health-related quality of life in fibromyalgia patients: a comparison with rheumatoid arthritis patients and the general population using the SF-36 health survey. Clin Exp Rheumatol 2009; 27: S67-74.
World Health Organization Quality of Life Group: Measuring quality of life. Available at: http: //www.who.int/mental health/media/68.pdf Accessed on January 29, 2013.
Salaffi F, Sarzi-Puttini P, Ciapetti A, Atzeni F. Assessment instruments for patients with fibromyalgia: properties, applications and interpretation. Clin Exp Rheumatol 2009; 27: S92-105.
Hoffman DL, Dukes EM. The health status of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12. Int J Clin Pract 2008; 62: 115-26. http://dx.doi.org/10.1111/j.1742-1241.2007.01638.x
Arnold LM, Crofford LJ, Mease PJ, et al. Patient Perspective on the Impact of Fibromyalgia. Patient Educ Couns 2008; 73: 114-20. http://dx.doi.org/10.1016/j.pec.2008.06.005
Walitt B, Fitzcharles MA, Hassett AL, Katz RS, Hauser W, Wolfe F. The longitudinal outcome of fibromyalgia: a study of 1555 patients. J Rheumatol 2011; 38: 2238-46. http://dx.doi.org/10.3899/jrheum.110026
Cacace E, Ruggiero V, Anedda C, Denotti A, Minerba L, Perpignano G. Quality of Life and associated clinical distress in fibromyalgia. Reumatismo 2006; 58: 226-9.
Verbunt JA, Pernot DH, Smeets RJ. Disability and quality of life in patients with fibromyalgia. Health Qual Life Outcomes 2008; 6: 8. http://dx.doi.org/10.1186/1477-7525-6-8
Yoshikawa GT, Heymann RE, Helfenstein M Jr, Pollak DF. A comparison of quality of life, demographic and clinical characteristics of Brazilian men with fibromyalgia syndrome with male patients with depression. Rheumatol Int 2010; 30: 473-8. http://dx.doi.org/10.1007/s00296-009-0994-4
Fietta P, Fietta P, Manganelli P. Fibromyalgia and psychiatric disorders. Acta Biomed 2007; 78: 88: 95.
Harris RE, Clauw DJ. Newer treatments for fibromyalgia syndrome. Ther Clin Risk Manag 2008; 4: 1331-42.
Gormsen L, Rosenberg R, Bach FW, Jansen TS. Depression, anxiety, health-related Quality of Life and pain in patients with chronic fibromyalgia and neuropathic pain. Eur J Pain 2010; 14: 127 E1-8.
Vishne T, Fostick L, Silberman A, Kupchick M, Rubinow A, Amital H, et al. Fibromyalgia among major depression disorder females compared to males. Rheumatol Int 2008; 28: 831-6. http://dx.doi.org/10.1007/s00296-008-0533-8
Aguglia A, Salvi V, Maina G, Rossetto I, Aguglia E. Fibromyalgia syndrome and depressive symptoms: Co-morbidity and clinical correlates. J Affect Disord 2011; 128: 262-6. http://dx.doi.org/10.1016/j.jad.2010.07.004
Lange M, Petermann F. Influence of depression on fibromyalgia: A systematic review. Schmerz 2010; 24: 326-33. http://dx.doi.org/10.1007/s00482-010-0937-8
Roy-Byrne P, Smith WR, Goldberg J, Afari N, Buchwald D. Post-traumatic stress disorder among patients with chronic pain and chronic fatigue. Psychol Med 2004; 34: 363-8. http://dx.doi.org/10.1017/S0033291703008894
Amital D, Fostick L, Polliack ML, Segev S, Zohar J, Rubinow A, et al. Posttraumatic stress disorder, tenderness, and fibromyalgia syndrome: are they different entities? J Psychosom Res 2006; 61: 663-9. http://dx.doi.org/10.1016/j.jpsychores.2006.07.003
Theadom A, Cropley M, Humphrey KL. Exploring the role of sleep and coping in quality of life in fibromyalgia. J Psychosom Res 2007; 62: 145-51. http://dx.doi.org/10.1016/j.jpsychores.2006.09.013
Bigatti SM, Hernandez AM, Cronan TA, Rand KL. Sleep disturbances in fibromyalgia syndrome: relationship to pain and depression. Arthritis Rheum 2008; 59: 961-7. http://dx.doi.org/10.1002/art.23828
Moldofsky H. The significance of dysfunctions of the sleeping/waking brain to the pathogenesis and treatment of fibromyalgia syndrome. Rheum Dis Clin North Am 2009; 35: 275-83. http://dx.doi.org/10.1016/j.rdc.2009.05.008
Mathieu N. Somatic comorbidities in irritable bowel syndrome: fibromyalgia, chronic fatigue syndrome, and interstitial cystitis. Gastroenterol Clin Biol 2009; 33: S17-25. http://dx.doi.org/10.1016/S0399-8320(09)71521-0
Buskila D, Sarzi-Puttini P. Fibromyalgia and Autoimmune Diseases: the Pain behind Autoimmunity. AMAJ 2008; 10: 77-78.
Kuriya B, Gladman DD, Ibañez D, Urowitz MB. Quality of life over time in patients with systemic lupus erythematosus. Arthritis Rheum 2008; 59: 181-5. http://dx.doi.org/10.1002/art.23339
Wolfe F, Petri M, Alarcón GS, Goldman J, Chakravarty EF, Katz RS, et al. Fibromyalgia, systemic lupus erythematosus (SLE), and evaluation of SLE. Activity. J Rheumatol 2009; 36: 82-8.
Ranzolin A, Brenol JC, Bredemeier M, Guarienti J, Rizzatti M, Feldman D, et al. Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short 36 scores in patients with rheumatoid arthritis. Arthritis Rheum 2009; 61: 794-800. http://dx.doi.org/10.1002/art.24430
Buskila D. Hepatitis C-associated rheumatic disorders. Rheum Dis Clin North Am 2009; 35: 111-23. http://dx.doi.org/10.1016/j.rdc.2009.03.005
Ifergane G, Buskila D, Simiseshvely N, Zeev K, Cohen H. Prevalence of fibromyalgia syndrome in migraine patients. Cephalalgia 2006; 26: 451-6. http://dx.doi.org/10.1111/j.1468-2982.2005.01060.x
Kalichman L. Association between fibromyalgia and sexual dysfunction in women. Clin Rheumatol 2009; 28: 365-9. http://dx.doi.org/10.1007/s10067-009-1093-3
Orellana C, Gratacós J, Galisteo C, Larrosa M. Sexual dysfunction in patients with fibromyalgia. Curr Rheumatol Rep 2009; 11: 437-42. http://dx.doi.org/10.1007/s11926-009-0064-7
Lee YC, Chen PP. A review of SSRIs and SNRIs in neuropathic pain. Expert Opin Pharmacother 2010; 11: 2813-25. http://dx.doi.org/10.1517/14656566.2010.507192
Moore RA, Straube S, Paine J, Phillips CJ, Derry S, McQuay HJ. Fibromyalgia: Moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain. Pain 2010; 149: 360-4. http://dx.doi.org/10.1016/j.pain.2010.02.039
Wu SC, Wrobel JS, Armstrong DG. Assessing the impact of pharmacologic intervention on the quality of life in diabetic peripheral neuropathic pain and fibromyalgia. Pain Med 2007; 8: S33-42. http://dx.doi.org/10.1111/j.1526-4637.2007.00350.x
Häuser W, Bernardy K, Uçeyler N, Sommer C. Treatment of fibromyalgia syndrome with gabapentin and pregabalin- a meta-analysis of randomized controlled trials. Pain 2009; 145: 69-81. http://dx.doi.org/10.1016/j.pain.2009.05.014
Häuser W, Petzke F, Sommer C. Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in Fibromyalgia syndrome. J Pain 2010; 11: 505-21. http://dx.doi.org/10.1016/j.jpain.2010.01.002
Owen RT. Pregabalin: Its efficacy, safety and tolerability profile in fibromyalgia syndrome. Drugs Today (Barc) 2007; 43: 857-63. http://dx.doi.org/10.1358/dot.2007.43.12.1140689
Straube S, Derry S, Moore RA, McQuay HJ. Pregabalin in Fibromyalgia: meta-analysis of efficacy and safety from company clinical trial reports. Rheumatology (Oxford) 2010; 49: 706-15. http://dx.doi.org/10.1093/rheumatology/kep432
Zareba G. New treatment options in the management of fibromyalgia: role of pregabalin. Neuropsychiatr Dis Treat 2008; 4: 1193-201. http://dx.doi.org/10.2147/NDT.S3257
Üçeyler N, Offenbächer M, Petzke F, Häuser W, Sommer C. New treatment for fibromyalgia: critical appraisal of duloxetine. Neuropsychiatr Dis Treat 2008; 4: 525-29.
Crofford LJ, Rowbotham MC, Mease PJ, Russell IJ, Dworkin RH, Corbin AE, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005; 52: 1264-73. http://dx.doi.org/10.1002/art.20983
Mease PJ, Russell IJ, Arnold LM, Florian H, Young JP Jr, Martin SA, et al. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol 2008; 35: 502-14.
Russell IJ, Mease PJ, Smith TR, Kajdasz DK, Wohlreich MM, Detke MJ, et al. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain 2008; 136: 432-44. http://dx.doi.org/10.1016/j.pain.2008.02.024
Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 2004; 50: 2974-84. http://dx.doi.org/10.1002/art.20485
Arnold LM, Rosen A, Pritchett YL, D'Souza DN, Goldstein DJ, Iyengar S, et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 2005; 119: 5-15. http://dx.doi.org/10.1016/j.pain.2005.06.031
Arnold LM, Clauw DJ, Wohlreich MM, Wang F, Ahl J, Gaynor PJ, et al. Efficacy of Duloxetine in patients with fibromyalgia: Pooled analysis of 4 placebo-controlled clinical trials. Prim Care Companion J Clin Psychiatry 2009; 11: 237-44. http://dx.doi.org/10.4088/PCC.08m00680
Danckaerts M. The quality of life of children with ADHD: a systematic review. Eur Child Adolesc Psychiatry 2010; 19: 83-105. http://dx.doi.org/10.1007/s00787-009-0046-3
Häuser W, Petzke F, Sommer C. Systematic Review with Meta-analysis: Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in Fibromyalgia syndrome. J Pain 2010; 11: 505-21. http://dx.doi.org/10.1016/j.jpain.2010.01.002
Chappell AS, Littlejohn G, Kajdasz DK, Scheinberg M, D'Souza DN, Moldofsky H. A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia. Clin J Pain 2009; 25: 365-75. http://dx.doi.org/10.1097/AJP.0b013e31819be587
Mease PJ, Russell IJ, Kajdasz DK, Wiltse CG, Detke MJ, Wohlreich MM, et al. Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia. Semin Arthritis Rheum 2010; 39: 454-64. http://dx.doi.org/10.1016/j.semarthrit.2008.11.001
Lawson K. Treatment options and patient perspectives in the management of fibromyalgia: future trends. Neuropsychiatr Dis Treat 2008; 4: 1059-71. http://dx.doi.org/10.2147/NDT.S3468
Kranzler JD, Gendreau RM. Role and rationale for the use of milnacipran in the management of fibromyalgia. Neuropsychiatr Dis Treat 2010; 6: 197-208. http://dx.doi.org/10.2147/NDT.S9622
Geisser ME, Palmer RH, Gendreau RM, Wang Y, Clauw DJ. A pooled analysis of two randomized, double-blind, placebo-controlled trials of milnacipran monotherapy in the treatment of fibromyalgia. Pain Pract 2011; 11: 120-31. http://dx.doi.org/10.1111/j.1533-2500.2010.00403.x
Arnold LM, Palmer RH, Gendreau RM, Chen W. Relationships among pain, depressed mood, and global status in fibromyalgia patients: post hoc analyses of a randomized, placebo-controlled trial of milnacipran. Psychosomatics 2012; 53: 371-9. http://dx.doi.org/10.1016/j.psym.2012.02.005
Clauw DJ, Mease P, Palmer RH, Gendreau RM, Wang Y. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther 2008; 30: 1988-2004. http://dx.doi.org/10.1016/j.clinthera.2008.11.009
Vitton O, Gendreau M, Gendreau J, Kranzler J, Rao SG. A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia. Hum Psychopharmacol 2004; 19(Suppl 1): S27-35. http://dx.doi.org/10.1002/hup.622
Gendreau RM, Thorn MD, Gendreau JF, Kranzler JD, Ribeiro S, Gracely RH, et al. Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol 2005; 32: 1975-85.
Hauser W, Petzke F, Uceyler N, Sommer C. Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis. Rheumatology 2011; 50: 532-43. http://dx.doi.org/10.1093/rheumatology/keq354
Bennett RM, Kamin Mm Karim R, Rosenthal N. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. Am J Med 2003; 114: 537-45. http://dx.doi.org/10.1016/S0002-9343(03)00116-5
Schug SA. Combination analgesia in 2005 – a rational approach: focus on paracetamol- tramadol. Clin Rheumatol 2006; 25: S16-21. http://dx.doi.org/10.1007/s10067-006-0202-9
Skrabek RQ, Galimova L, Ethans K, Perry D. Nabilone for the treatment of pain in fibromyalgia. J Pain 2008; 29: 164-73. http://dx.doi.org/10.1016/j.jpain.2007.09.002
Ware MA, Fitzcharles MA, Joseph L, Shir Y. The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial. Anesth Analg 2010; 110: 604-10. http://dx.doi.org/10.1213/ANE.0b013e3181c76f70
Staud R, Koo EB. Are cannabinoids a new treatment option for pain in patients with fibromyalgia? Nat Clin Pract Rheumatol 2008; 4: 348-9.
Russell IJ, Perkins A T, Michalek JE. Sodium Oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial. Arthritis Rheum 2009; 60: 299-309. http://dx.doi.org/10.1002/art.24142
Schafranski MD, Malucelli T, Machado F, Takeshi H, Kaiber F, Schmidt C, et al. Intravenous lidocaine for fibromyalgia syndrome: an open trial. Clin Rheumatol 2009; 28: 853-5. http://dx.doi.org/10.1007/s10067-009-1137-8
Waaga-Gasser AM, Gasser M, Stock M, Grimm M, Sprotte G. Oral immunoglobulin induces mononuclear cell apoptosis in patients suffering from idiopathic chronic pain syndrome: results from a pilot study. Int J Clin Pharmacol Ther 2009; 47: 421-33. http://dx.doi.org/10.5414/CPP47421
Burckhardt CS, Mannerkorpi K, Hedenberg L, Bjelle A. A randomized, controlled clinical trial of education and physical training for women with fibromyalgia. J Rheumatol 1994; 21: 714-20.
Stephens S, Feldman BM, Bradley N, Schneiderman J, Wright V, Singh-Grewal D, et al. Feasibility and effectiveness of an aerobic exercise program in children with fibromyalgia: results of a randomized controlled pilot trial. Arthritis Rheum 2008; 59: 1399-406. http://dx.doi.org/10.1002/art.24115
Sanudo B, Galiano D, Carrasco L, de Hoyo M, McVeigh JG. Effects of a prolonged exercise program on key health outcomes in women with fibromyalgia: a randomized controlled trial. J Rehabilit Med 2011; 43: 521-6. http://dx.doi.org/10.2340/16501977-0814
Tomas-Carus P, Gusi N, Häkkinen A, Häkkinen K, Raimundo A, Ortega-Alonso A. Improvement of muscle strength predicted benefits in HRQOL and postural balance in women with fibromyalgia: an 8-month randomized controlled trial. Rheumatology (Oxford) 2009; 48: 1147-51. http://dx.doi.org/10.1093/rheumatology/kep208
Sañudo B, Carrasco L, de Hoyo M, McVeigh JG. Effects of exercise training and detraining in patients with fibromyalgia syndrome: a 3-yr longitudinal study. Am J Phys Med Rehabil 2012; 91: 561-9. http://dx.doi.org/10.1097/PHM.0b013e31824faa03
Kayo AH, Peccin MS, Sanches CM, Trevisani VF. Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatol Int 2012; 32: 2285-92. http://dx.doi.org/10.1007/s00296-011-1958-z
Taggart HM, Arslanian CL, Bae S, Singh K. Effects of T'ai Chi exercise on fibromyalgia symptoms and health-related quality of life. Orthop Nurs 2003; 22: 353-60. http://dx.doi.org/10.1097/00006416-200309000-00013
Wang C, Schmid CH, Rones R, Kalish R, Yinh J, Goldenberg DL, et al. A randomized trial of tai chi for fibromyalgia. N Engl J Med 2010; 363(8): 743-54. http://dx.doi.org/10.1056/NEJMoa0912611
Häuser W, Klose P, Langhorst J, Moradi B, Steinbach M, Schiltenwolf M, et al. Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta- analysis of randomized controlled trials. Arthritis Res Ther 2010; 12: R79. http://dx.doi.org/10.1186/ar3002
Gusi N, Tomas-Carus P, Häkkinen A, Häkkinen K, Ortega-Alonso A. Exercise in waist-high warm water decreases pain and improves health-related quality of life and strength in the lower extremities in women with fibromyalgia. Arthritis Rheum 2006; 55: 66-73. http://dx.doi.org/10.1002/art.21718
Ortega E, Bote ME, Giraldo E, García JJ. Aquatic exercise improves the monocyte pro-and anti-inflammatory cytokine production balance in fibromyalgia patients. Scand J Med Sci Sports 2010; 22: 104-12. http://dx.doi.org/10.1111/j.1600-0838.2010.01132.x
Tomas-Carus P, Häkkinen A, Gusi N, Leal A, Häkkinen K, Ortega-Alonso A. Aquatic training and detraining on fitness and quality of life in fibromyalgia. Med Sci Sports Exerc 2007; 39: 1044-50. http://dx.doi.org/10.1249/01.mss.0b0138059aec4
Olivares PR, Gusi N, Parraca JA, Adsuar JC, Del Pozo-Cruz B. Tilting Whole Body Vibration improves quality of life in women with fibromyalgia: a randomized controlled trial. J Altern Compl Med 2011; 17: 723-8. http://dx.doi.org/10.1089/acm.2010.0296
Vitorino DF, Carvalho LB, Prado GF. Hydrotherapy and conventional physiotherapy improve total sleep time and quality of life of fibromyalgia patients: randomized clinical trial. Sleep Med 2006; 7: 293-6. http://dx.doi.org/10.1016/j.sleep.2005.09.002
Targino RA, Imamura M, Kaziyama HH, Souza LP, Hsing WT, Furlan AD, et al. A randomized controlled trial of acupuncture added to usual treatment for fibromyalgia. J Rehabil Med 2008; 40: 582-8. http://dx.doi.org/10.2340/16501977-0216
Itoh K, Kitakoji H. Effects of acupuncture to treat fibromyalgia: in preliminary randomized controlled trials. Chin Med 2010; 5: 11. http://dx.doi.org/10.1186/1749-8546-5-11
Singh BB, Khorsan R, Vinjamury SP. Influence of comorbidities on improvement of fibromyalgia symptoms when treated with acupuncture: a short report. Altern Ther Health Med 2008; 14: 24-5.
Furlong LV, Zautra A, Puerite CP, López-López A, Valero PB. Cognitive-affective assets and vulnerabilities: two factors influencing adaptation to fibromyalgia. Psychol Health 2010; 25: 197-12. http://dx.doi.org/10.1080/08870440802074656
Casale R, Cazzola M, Arioli G, Gracely RH, Ceccherelli F, Atzeni F, et al. Non pharmacological treatments in fibromyalgia. Reumatismo 2008; 60: 59-69.
Bernardy K, Füber N, Köllner V, Häuser W. Efficacy of Cognitive-Behavioral Therapy in Fibromyalgia Syndrome- A Systematic Review and Meta-analysis of Randomized Controlled Trials. J Rheumatol 2010; 37: 1991-2005. http://dx.doi.org/10.3899/jrheum.100104
Kashikar-Zuck S, Ting TV, Arnold LM, Bean J, Powers SW, Graham TB, et al. Cognitive behavioral therapy for the treatment of juvenile fibromyalgia: a multisite, single-blind, randomized, controlled clinical trial. Arthritis Rheum 2012; 64: 297-305. http://dx.doi.org/10.1002/art.30644
Kayiran S, Dursun E, Ermutlu N, Dursun N, Karamürsel S. Neurofeedback in fibromyalgia syndrome. Agri 2007; 19: 47-53. http://dx.doi.org/10.1007/s10484-010-9135-9
Kayiran S, Dursun E, Dursun N, Ermutlu N, Karamürsel S. Neurofeedback intervention in Fibromyalgia Syndrome; a Randomized, Controlled, Rater Blind Clinical Trial. Appl Psychophysiol Biofeedback 2010; 35: 293-302.
Scascighini L, Toma V, Dober-Spielmann S, Sprott H. Multidisciplinary treatment for chronic pain: a systematic review of interventions and outcomes. Rheumatology (Oxford) 2008; 47: 670-8. http://dx.doi.org/10.1093/rheumatology/ken021
Van Abbema R, Van Wilgen CP, Van Der Schans CP, Van Ittersum MW. Patients with more severe symptoms benefit the most from an intensive multimodal programme in patients with fibromyalgia. Disabil Rehabil 2010; 33: 743-50. http://dx.doi.org/10.3109/09638288.2010.510177
Häuser W, Bernardy K, Arnold B, Offenbächer M, Schiltenwolf M. Efficacy of multicomponent treatment in fibromyalgia syndrome: a meta-analysis of randomized controlled clinical trials. Arthritis Rheum 2009; 61: 216-24. http://dx.doi.org/10.1002/art.24276
Carbonell-Baeza A, Aparicio VA, Chillón P, Femia P, Delgado-Fernandez M, Ruiz JR. Effectiveness of multidisciplinary therapy on symptomatology and quality of life in women with fibromyalgia. Clin Exp Rheumatol 2011; 29(6 Suppl 69): S97-103.
Schmidt S, Grossman P, Schwarzer B, Jena S, Naumann J, Walach H. Treating fibromyalgia with mindfulness-based stress reduction: results from a 3-armed randomized controlled trial. Pain 2011; 152: 361-9. http://dx.doi.org/10.1016/j.pain.2010.10.043
Bernardy K, Fuber N, Klose P, Hauser W. Efficacy of hypnosis/guided imagery in fibromyalgia syndrome-a systematic review and meta-analysis of controlled trials. BMC Musculoskeletal Disorders 2011; 12: 133. http://dx.doi.org/10.1186/1471-2474-12-133
Fiz J, Duran M, Capella D, Carbonell J, Farre M. Cannabis use in patients with fibromyalgia: effect on symptoms relief and health-related quality of life. PLoS One 2011 6: e18440, 2011.
